U.S. market Closed. Opens in 17 hours 10 minutes

ADIL | Adial Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue564.0060.50K55.11K564.00565.00N/AN/AN/AN/A
Gross Profit-564.00-60.50K-55.11K-564.00-565.00N/AN/AN/AN/A
Operating Expenses6.89M13.32M17.74M10.93M8.24M6.99M995.29K410.81KN/A
Selling, General & Admin5.62M9.14M9.34M5.07M4.28M6.62M813.18K264.66K497.15K
Research & Development1.27M4.18M8.40M5.85M3.97M368.46K182.11K146.14K322.11K
Other Operating ExpensesN/AN/A46.49K2.50KN/AN/AN/AN/A-819.26K
Operating Income-6.89M-13.32M-19.29M-10.93M-8.24M-6.99M-995.29K-410.81K-819.26K
Other Expenses / Income-113.94K585.21K-228.68K34.99K-346.53K-3.48M-144.17K-9.39K1.26K
Before Tax Income-7.00M-12.73M-19.52M-10.89M-8.59M-11.63M-1.14M-420.20K-817.99K
Income Tax Expenses-1.88M-502.00-94.08K-32.49K-76.06K-3.48MN/AN/AN/A
Net Income-7.75M-12.73M-19.42M-10.86M-8.59M-11.63M-1.14M-420.20K-817.99K
Interest ExpensesN/A-585.21KN/AN/AN/A1.17M144.54K9.64KN/A
Basic Shares Outstanding1.42M40.06K743.55K498.52K394.10K190.37K4.78M3.99M4.78M
Diluted Shares Outstanding1.42M40.06K743.55K498.52K394.10K190.37K4.78M3.99M4.78M
EBITDA-6.89M-13.78M-15.86M-10.93M-8.15M-6.98M-994.35K-410.00K-817.43K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-9.63M-13.32M-19.52M-10.89M-8.67M-13.94M-994.92K-410.56K-817.99K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙